mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.4 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |